Mochida Initiates Phase III Study of BON-001 in Japan
Mochida Pharmaceutical has initiated a Phase III clinical study of BON-001 for nausea and vomiting of pregnancy in Japan.
Mochida Pharmaceutical has initiated a Phase III clinical study of BON-001 for nausea and vomiting of pregnancy in Japan.